Latest Breaking News On - European innovative medicines initiative - Page 1 : comparemela.com

Spexis provides business update and announces financial

Spexis provides business update and announces financial results for the first half of 2023.

United statesSwitzerland generalUnited kingdomHernan levettStephan feldhausOliver zerbeStephen jasperMaxim groupTrinity hall collegeUniversity of oxfordAmerican cancer societyBlavatnik family foundationEuropean research councilEuropean federation of medicinal chemistryUniversity of zurichEuropean innovative medicines initiative

Spexis provides business update and announces financial results for the first half of 2023 - adhoc - Börsennachrichten

Spexis AG Key word Half Year Results Spexis provides business update and announces financial results for the first half of 2023 29Sep2023 0725 CETCEST Release of an ad hoc announcement pursuant to Ar

Switzerland generalUnited statesUnited kingdomStephan feldhausOliver zerbeStephen jasperHernan levettUniversity of zurichEuropean federation of medicinal chemistrySwiss federal institute of technologyEuropean innovative medicines initiativeGilmartin groupInternational chemical biology societyRoyal society of chemistryMaxim groupTrinity hall college

Adhoc: Spexis AG: Spexis provides business update and announces financial results for the first half of 2023

Adhoc: Spexis AG: Spexis provides business update and announces financial results for the first half of 2023
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Baden wübergUnited kingdomSwitzerland generalUnited statesOliver zerbeStephan feldhausStephen jasperHernan levettBlavatnik family foundationTrinity hall collegeAmerican cancer societyMaxim groupSwiss federal institute of technologyGilmartin groupUniversity of zurichRoyal society of chemistry

Spexis provides business update and announces financial results for the first half of 2023

Spexis provides business update and announces financial results for the first half of 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesSwitzerland generalOliver zerbeRoyal society of chemistryInternational chemical biology societyEuropean innovative medicines initiativeSwiss federal institute of technologyEuropean federation of medicinal chemistryUniversity of zurichEuropean research councilBlavatnik family foundationStephen jasper managing directorgilmartin groupAmerican cancer societyUniversity of oxfordTrinity hall college

Promising first-in-human study results for orally inhaled antibiotic

Safety results from a first-in-human study showed that orally inhaled macrocycle compound murepavadin was well tolerated at all dose levels.

Juergen froehlichEuropean innovative medicines initiativeOuter membrane protein targeting antibioticsChief medical officer